AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 19648568 — intervention group
Group type: EXPERIMENTAL
Intervention: CAI (computer‐assisted instruction) using DVD technology
Number of subjects: 73
Study 19648568 — intervention group
Group type: COMPARATOR
Intervention: Traditional laboratory instruction
Number of subjects: 73
Study 17218618 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Positive Airway Pressure (CPAP) therapy for 4 to 6 weeks
Number of subjects: 8
Study 17218618 — intervention group
Group type: COMPARATOR
Intervention: Control subjects (matched healthy control subjects)
Number of subjects: 8
Study 17218618 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with OSA before CPAP therapy
Number of subjects: 8
Study 15891124 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg thalidomide daily for one week, followed by 50 mg/day for weeks 2 and 3, then dummy capsules in weeks 4 through 7.
Number of subjects: 22
Study 15891124 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg thalidomide daily for one week, followed by gradual decrements every two weeks.
Number of subjects: 22
Study 12499621 — intervention group
Group type: EXPERIMENTAL
Intervention: Thallium-201 myocardial scintigraphy (Tl-201)
Number of subjects: 47
Study 12499621 — intervention group
Group type: COMPARATOR
Intervention: Heart-to-mediastinum (H/M) MIBG uptake ratio
Number of subjects: 47
Study 12499621 — intervention group
Group type: COMPARATOR
Intervention: Percent washout ratio of myocardial MIBG
Number of subjects: 47
Study 9585310 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine 0.2-0.3 mg per os
Number of subjects: 22
Study 9585310 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 7712843 — intervention group
Group type: EXPERIMENTAL
Intervention: 120mg calcium daily
Number of subjects: 212
Study 7712843 — intervention group
Group type: EXPERIMENTAL
Intervention: 240mg calcium daily
Number of subjects: 212
Study 7712843 — intervention group
Group type: EXPERIMENTAL
Intervention: 1g calcium daily
Number of subjects: 212
Study 7712843 — intervention group
Group type: EXPERIMENTAL
Intervention: 2g calcium daily
Number of subjects: 212
Study 7712843 — intervention group
Group type: COMPARATOR
Intervention: Control group (no calcium supplementation)
Number of subjects: 212
Study 7712843 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-calcium supplementation cases)
Number of subjects: 212
Study 2719293 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 ml saline solution and 0.5 ml clonidine (75 micrograms)
Number of subjects: 44
Study 2719293 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 ml clonidine (150 micrograms)
Number of subjects: 44
Study 2719293 — intervention group
Group type: COMPARATOR
Intervention: 15 mg of 0.5% hyperbaric tetracaine (HT) + 1 ml isotonic saline
Number of subjects: 44
Study 785915 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexon sutures
Number of subjects: 308
Study 785915 — intervention group
Group type: COMPARATOR
Intervention: Mersilene sutures
Number of subjects: 308
Study 29654915 — intervention group
Group type: EXPERIMENTAL
Intervention: MaZiRenWan (MZRW) 7.5 g, twice daily
Number of subjects: 291
Study 29654915 — intervention group
Group type: COMPARATOR
Intervention: Senna 15 mg daily
Number of subjects: 291
Study 29654915 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 291
Study 28982816 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct transport to specialist neuroscience centres (SNCs) bypassing nearest non-specialist acute hospitals (NSAHs)
Number of subjects: 293
Study 28982816 — intervention group
Group type: COMPARATOR
Intervention: Transport to nearest NSAH with selective secondary transfer to SNC
Number of subjects: 293
Study 28982816 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct transport to SNCs bypassing nearest NSAHs
Number of subjects: 293
Study 26618469 — intervention group
Group type: EXPERIMENTAL
Intervention: Merz Hand Grading Scale (MHGS)
Number of subjects: 84
Study 23358971 — intervention group
Group type: EXPERIMENTAL
Intervention: Exemestane
Number of subjects: 7576
Study 23358971 — intervention group
Group type: COMPARATOR
Intervention: Anastrozole
Number of subjects: 7576
Study 23358971 — intervention group
Group type: EXPERIMENTAL
Intervention: Exemestane and Anastrozole
Number of subjects: 7576
Study 22078420 — intervention group
Group type: COMPARATOR
Intervention: SAVR
Number of subjects: 442
Study 22078420 — intervention group
Group type: COMPARATOR
Intervention: TAVI
Number of subjects: 442
Study 22078420 — intervention group
Group type: EXPERIMENTAL
Intervention: MT
Number of subjects: 442
Study 19589305 — intervention group
Group type: EXPERIMENTAL
Intervention: Flatfoot group
Number of subjects: 25
Study 19589305 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 25
Study 16840386 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril (ACE inhibitor group)
Number of subjects: 40
Study 16840386 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy with ferrous sulfate, 525 mg
Number of subjects: 40
Study 12867205 — intervention group
Group type: EXPERIMENTAL
Intervention: Methadone treatment (mean daily dose 50 mg) in general practice
Number of subjects: 240
Study 12867205 — intervention group
Group type: EXPERIMENTAL
Intervention: Methadone treatment (mean daily dose 50 mg) in specialist clinics
Number of subjects: 240
Study 12867205 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 240
Study 10709792 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition education
Number of subjects: 732
Study 10709792 — intervention group
Group type: COMPARATOR
Intervention: Stress management classes (attention-placebo group)
Number of subjects: 732
Study 9209246 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous infusion of 500 mg azithromycin
Number of subjects: 12
Study 9209246 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral administration of two 250 mg azithromycin capsules
Number of subjects: 12
Study 8221740 — intervention group
Group type: EXPERIMENTAL
Intervention: Gallopamil (GAL) 50 mg tid
Number of subjects: 15
Study 8221740 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine (AML) 10 mg/daily
Number of subjects: 15
Study 8221740 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 3550031 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine
Number of subjects: 99
Study 30717693 — intervention group
Group type: EXPERIMENTAL
Intervention: Test & Treat TB intervention with immediate GeneXpert testing; participants received expedited TB treatment initiation, monthly SMS reminders, and non-cash incentives.
Number of subjects: 4815
Study 30717693 — intervention group
Group type: COMPARATOR
Intervention: Usual mobile unit care (providing sputum on the mobile unit sent out for GeneXpert testing).
Number of subjects: 4815
Study 29101973 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based interactive report
Number of subjects: 193
Study 29101973 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient letter
Number of subjects: 193
Study 29101973 — intervention group
Group type: COMPARATOR
Intervention: Standard report
Number of subjects: 193
Study 25483170 — intervention group
Group type: EXPERIMENTAL
Intervention: Community Walking Training Program (CWTP) for 30 min per day, five times a week, for four weeks
Number of subjects: 22
Study 25483170 — intervention group
Group type: COMPARATOR
Intervention: Standard rehabilitation program (physical and occupational therapy for 60 min per day, five times a week, for four weeks)
Number of subjects: 22
Study 23159962 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 mL bupivacaine 0.125% and 8 mg dexamethasone in a total volume of 8 mL (Group 2)
Number of subjects: 64
Study 23159962 — intervention group
Group type: COMPARATOR
Intervention: 8 mL saline (Group 1)
Number of subjects: 64
Study 19041254 — intervention group
Group type: EXPERIMENTAL
Intervention: Self management group using CoaguChek
Number of subjects: 62
Study 19041254 — intervention group
Group type: COMPARATOR
Intervention: Conventional group controlled by the Local Thrombosis Service
Number of subjects: 62
Study 17880315 — intervention group
Group type: EXPERIMENTAL
Intervention: Peripherally inserted central catheter
Number of subjects: 74
Study 17880315 — intervention group
Group type: COMPARATOR
Intervention: Peripheral intravenous catheter
Number of subjects: 74
Study 12766625 — intervention group
Group type: COMPARATOR
Intervention: Ethanol (0.5 g/kg)
Number of subjects: 16
Study 12766625 — intervention group
Group type: COMPARATOR
Intervention: d-Amphetamine (0, 5, 10, and 15 mg)
Number of subjects: 16
Study 11912811 — intervention group
Group type: EXPERIMENTAL
Intervention: DCCT protocol implementation with a diabetes clinical nurse specialist program coordinator
Number of subjects: 124
Study 11912811 — intervention group
Group type: EXPERIMENTAL
Intervention: DCCT protocol implementation
Number of subjects: 124
Study 8741076 — intervention group
Group type: EXPERIMENTAL
Intervention: levodopa methyl ester (LDME)
Number of subjects: 34
Study 1330761 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcitonin
Number of subjects: 104
Study 1330761 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogen/progestogen (HRT) plus calcitonin
Number of subjects: 104
Study 1330761 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogen/progestogen (HRT)
Number of subjects: 104
Study 1330761 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 104
Study 3936140 — intervention group
Group type: EXPERIMENTAL
Intervention: Almitrine bismesylate (200 mg/day for 9 days)
Number of subjects: 18
Study 3726048 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic training
Number of subjects: 38
Study 3726048 — intervention group
Group type: EXPERIMENTAL
Intervention: Anaerobic training (weight-lifting)
Number of subjects: 38
Study 3726048 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control
Number of subjects: 38
Study 31375462 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional information provided to half of the participants (n=150)
Number of subjects: 290
Study 31375462 — intervention group
Group type: COMPARATOR
Intervention: No nutritional information provided (control group)
Number of subjects: 290
Study 31375462 — intervention group
Group type: EXPERIMENTAL
Intervention: Chocolate consumption
Number of subjects: 290
Study 31375462 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported hunger prior to the study
Number of subjects: 290
Study 31375462 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional information
Number of subjects: 290
Study 29618841 — intervention group
Group type: EXPERIMENTAL
Intervention: Aliskiren
Number of subjects: 39
Study 29618841 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine
Number of subjects: 39
Study 28585143 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-allergen sublingual immunotherapy (SLIT) with a single HDM extract
Number of subjects: 78
Study 28585143 — intervention group
Group type: COMPARATOR
Intervention: Multi-allergen subcutaneous immunotherapy (SCIT) with multiple-allergen extracts (HDM and other allergens)
Number of subjects: 78
Study 26121900 — intervention group
Group type: EXPERIMENTAL
Intervention: Subtenon bupivacaine 0.5%
Number of subjects: 60
Study 26121900 — intervention group
Group type: COMPARATOR
Intervention: Saline injection (control)
Number of subjects: 60
Study 23640321 — intervention group
Group type: EXPERIMENTAL
Intervention: Proprioceptive resistance training (PRT)
Number of subjects: 26
Study 23640321 — intervention group
Group type: COMPARATOR
Intervention: Resistance training (RT)
Number of subjects: 26
Study 20087780 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic tumor-specific rectal surgery (RTSRS)
Number of subjects: 143
Study 19034219 — intervention group
Group type: EXPERIMENTAL
Intervention: ATG-Fresenius (9 mg/kg day 0; 3 mg/kg day 1-4)
Number of subjects: 22
Study 19034219 — intervention group
Group type: COMPARATOR
Intervention: Daclizumab (1 mg/kg day 0, 14, 28, 42, 56)
Number of subjects: 22
Study 16598296 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 mg Altastaph/kg
Number of subjects: 206
Study 16598296 — intervention group
Group type: COMPARATOR
Intervention: 0.45% NaCl placebo
Number of subjects: 206
Study 12947437 — intervention group
Group type: EXPERIMENTAL
Intervention: Filtered coffee 600 ml/day for 4 weeks
Number of subjects: 121
Study 12947437 — intervention group
Group type: COMPARATOR
Intervention: Coffee abstention for 3 weeks
Number of subjects: 121
Study 10625238 — intervention group
Group type: EXPERIMENTAL
Intervention: First hepatic artery revascularization
Number of subjects: 59
Study 10625238 — intervention group
Group type: COMPARATOR
Intervention: First portal vein revascularization
Number of subjects: 59
Study 9100202 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetracycline hydrochloride (50 mg/ml) root treatment for 5 minutes (TTC‐HCl group)
Number of subjects: 30
Study 9100202 — intervention group
Group type: COMPARATOR
Intervention: Citric acid root treatment for 3 minutes (CA group)
Number of subjects: 30
Study 7903034 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine and sulphasalazine combination treatment
Number of subjects: 91
Study 7903034 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine alone
Number of subjects: 91
Study 7903034 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulphasalazine alone
Number of subjects: 91
Study 7903034 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 91
Study 3861844 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivitamin and mineral supplements
Number of subjects: 33
Study 3861844 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 31916533 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional pharmacological treatment plus respiratory physiotherapy (breathing and airway clearance techniques, exercise training, education for 3 weeks, 3 times per week)
Number of subjects: 97
Study 31916533 — intervention group
Group type: COMPARATOR
Intervention: Conventional pharmacological treatment (control group)
Number of subjects: 97
Study 30593551 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic counselling and disclosure of estimated future cardiovascular risk based on genetic testing results.
Number of subjects: 0
Study 30593551 — intervention group
Group type: COMPARATOR
Intervention: Standard patients' education programme without genetic counselling.
Number of subjects: 0
Study 27538798 — intervention group
Group type: EXPERIMENTAL
Intervention: HFOV recruitment maneuver (IN-REC-SUR-E)
Number of subjects: 206
Study 27538798 — intervention group
Group type: COMPARATOR
Intervention: No recruitment maneuver (IN-SUR-E)
Number of subjects: 206
Study 24984177 — intervention group
Group type: EXPERIMENTAL
Intervention: Indapamide sustained-release 1.5 mg with the addition of perindopril 2-4 mg as required
Number of subjects: 3845
Study 23324363 — intervention group
Group type: EXPERIMENTAL
Intervention: Rod colostomy
Number of subjects: 42
Study 23324363 — intervention group
Group type: COMPARATOR
Intervention: Skin bridge colostomy
Number of subjects: 42
Study 20302646 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole grain diet
Number of subjects: 20
Study 20302646 — intervention group
Group type: COMPARATOR
Intervention: Refined grain diet
Number of subjects: 20
Study 18245142 — intervention group
Group type: EXPERIMENTAL
Intervention: SFC+TIO (salmeterol/fluticasone propionate + tiotropium bromide)
Number of subjects: 41
Study 18245142 — intervention group
Group type: EXPERIMENTAL
Intervention: SFC+TIO
Number of subjects: 41
Study 18245142 — intervention group
Group type: COMPARATOR
Intervention: TIO
Number of subjects: 41
Study 18245142 — intervention group
Group type: COMPARATOR
Intervention: SFC
Number of subjects: 41
Study 16024091 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressant treatment with paroxetine
Number of subjects: 78
Study 16024091 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressant treatment with amitriptyline
Number of subjects: 78
Study 16024091 — intervention group
Group type: COMPARATOR
Intervention: Control group (11 healthy male subjects)
Number of subjects: 78
Study 12475578 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetic pregnancy (n=16)
Number of subjects: 57
Study 12475578 — intervention group
Group type: COMPARATOR
Intervention: Normal pregnancy (n=12, n=15, n=15)
Number of subjects: 57
Study 11105495 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose prednisolone treatment
Number of subjects: 9
Study 8800303 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole 150 mg once weekly
Number of subjects: 36
Study 8800303 — intervention group
Group type: COMPARATOR
Intervention: Griseofulvin 1,000 mg once daily
Number of subjects: 36
Study 1622115 — intervention group
Group type: COMPARATOR
Intervention: 5-FU
Number of subjects: 64
Study 1622115 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-FU + FA
Number of subjects: 64
Study 6324587 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic intravenous administration of hyperimmune cytomegalovirus IgG at a dose of 200 mg/kg on days 25, 50, and 75 following transplant
Number of subjects: 0
Study 6324587 — intervention group
Group type: COMPARATOR
Intervention: Supporting treatment control group
Number of subjects: 0
Study 30920117 — intervention group
Group type: EXPERIMENTAL
Intervention: Four-drug metronomic chemotherapy regimen (oral celecoxib b.i.d., weekly vinblastine, oral cyclophosphamide for three weeks alternating with oral methotrexate for three weeks, with a two-week rest)
Number of subjects: 44
Study 30920117 — intervention group
Group type: EXPERIMENTAL
Intervention: Four-drug metronomic chemotherapy regimen
Number of subjects: 44
Study 31156913 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist complex intervention (home visit at 1, 3, and 6 months) including medication review, medicines and lifestyle advice, PCI resolution, and supply of individualised patient information.
Number of subjects: 35
Study 31156913 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist complex intervention (home visit at 1, 3, and 6 months).
Number of subjects: 35
Study 31156913 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group).
Number of subjects: 35
Study 26803316 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal cleansing enemas
Number of subjects: 59
Study 24873024 — intervention group
Group type: EXPERIMENTAL
Intervention: Ostracized individuals
Number of subjects: 62
Study 24873024 — intervention group
Group type: COMPARATOR
Intervention: Included individuals
Number of subjects: 62
Study 24873024 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 62
Study 22101207 — intervention group
Group type: EXPERIMENTAL
Intervention: Facebook recruitment
Number of subjects: 730
Study 22101207 — intervention group
Group type: COMPARATOR
Intervention: Traditional recruitment methods
Number of subjects: 730
Study 19880673 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive exercise and risk reduction therapy including educational sessions, a low‐fat diet, and 2 hours of individually prescribed exercise daily.
Number of subjects: 16
Study 19880673 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 16
Study 17456521 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated smoking cessation treatment within mental health care
Number of subjects: 1400
Study 17456521 — intervention group
Group type: COMPARATOR
Intervention: Referral to specialized smoking cessation clinics (usual standard of care)
Number of subjects: 1400
Study 15311146 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Positive Airway Pressure (CPAP) therapy
Number of subjects: 122
Study 15311146 — intervention group
Group type: COMPARATOR
Intervention: No CPAP therapy (control group)
Number of subjects: 122
Study 15311146 — intervention group
Group type: EXPERIMENTAL
Intervention: CPAP therapy
Number of subjects: 122
Study 11136492 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonthoracotomy ICDs via subclavian route
Number of subjects: 539
Study 11136492 — intervention group
Group type: COMPARATOR
Intervention: Nonthoracotomy ICDs via cephalic vein route
Number of subjects: 539
Study 11136492 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonthoracotomy ICDs with abdominal generator site
Number of subjects: 539
Study 11136492 — intervention group
Group type: COMPARATOR
Intervention: Nonthoracotomy ICDs with pectoral generator site
Number of subjects: 539
Study 11136492 — intervention group
Group type: EXPERIMENTAL
Intervention: Failure to use perioperative antibiotics
Number of subjects: 539
Study 11136492 — intervention group
Group type: EXPERIMENTAL
Intervention: Lead fractures
Number of subjects: 539
Study 11136492 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine ICD system surveillance
Number of subjects: 539
Study 9634157 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive group treatment program (3 hours of group treatment, 3 days a week)
Number of subjects: 447
Study 9634157 — intervention group
Group type: COMPARATOR
Intervention: Weekly individual outpatient counseling
Number of subjects: 447
Study 9634157 — intervention group
Group type: COMPARATOR
Intervention: Weekly individual counseling plus one weekly group session
Number of subjects: 447
Study 9634157 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients who remained in treatment longer
Number of subjects: 447
Study 9634157 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients who remained in treatment
Number of subjects: 447
Study 7608845 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetracycline fiber therapy used adjunctively with scaling and root planing (S and RP)
Number of subjects: 113
Study 7608845 — intervention group
Group type: COMPARATOR
Intervention: Scaling and root planing (S and RP) alone
Number of subjects: 113
Study 3362944 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.75 ml/kg ethanol
Number of subjects: 20
Study 3362944 — intervention group
Group type: COMPARATOR
Intervention: Isocaloric placebo
Number of subjects: 20
Study 29617491 — intervention group
Group type: EXPERIMENTAL
Intervention: Elastic bandage and decongestant physical therapy
Number of subjects: 90
Study 29617491 — intervention group
Group type: COMPARATOR
Intervention: Elastic bandage
Number of subjects: 90
Study 29617491 — intervention group
Group type: COMPARATOR
Intervention: Primary dressing only
Number of subjects: 90
Study 28232142 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent coach-led well visits
Number of subjects: 115
Study 28232142 — intervention group
Group type: EXPERIMENTAL
Intervention: Well-Visit Planner
Number of subjects: 115
Study 28232142 — intervention group
Group type: EXPERIMENTAL
Intervention: Text message reminder/education service
Number of subjects: 115